Table 3.
Univariate analysis |
Multivariate analysis |
|||||||
χ2 value | HR | 95%CI | P value | χ2 value | HR | 95%CI | P value | |
Age | 21.774 | 1.373 | 1.202-1.569 | < 0.001 | 34.479 | 1.499 | 1.310-1.716 | < 0.001 |
Gender | 0.144 | - | - | 0.705 | ||||
Tumor location | 0.509 | - | - | 0.476 | ||||
Histological type | 20.091 | 1.447 | 1.231-1.701 | < 0.001 | ||||
Tumor size | 1.095 | - | - | 0.295 | ||||
T stage | 59.847 | 1.419 | 1.299-1.550 | < 0.001 | ||||
N stage | 86.718 | 1.354 | 1.270-1.443 | < 0.001 | ||||
M stage | 221.926 | 3.172 | 2.725-3.692 | < 0.001 | 31.580 | 2.024 | 1.583-2.589 | < 0.001 |
TNM stage | 179.589 | 1.673 | 1.552-1.804 | < 0.001 | 15.414 | 1.255 | 1.121-1.406 | < 0.001 |
NLR status | 36.441 | 1.518 | 1.325-1.738 | < 0.001 | ||||
PLR status | 20.826 | 1.369 | 1.196-1.567 | < 0.001 | ||||
SII status | 159.123 | 2.988 | 2.521-3.542 | < 0.001 | 129.495 | 2.717 | 2.287-3.228 | < 0.001 |
Chemotherapy | 61.159 | 1.716 | 1.499-1.965 | < 0.001 |
NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-lymphocyte ratio.